Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




RNA Binding Protein Required for Successful Infection by HCMV

By LabMedica International staff writers
Posted on 03 Nov 2016
A team of molecular virologists has catalogued the interactions that occur at the genetic level when cytomegalovirus (HCMV) infects human cells.

Investigators at the University of California, San Diego (USA) performed comprehensive transcriptome-wide analyses to better understand interactions occurring at the post-transcriptional level between the human host and HCMV.

They reported in the October 24, 2016, online edition of the journal Nature Structural and Molecular Biology that the host RNA-binding protein CPEB1 (Cytoplasmic polyadenylation element-binding protein 1) was highly induced after infection. More...
Introduction of CPEB1 into uninfected cells recapitulated the infection-related post-transcriptional changes seen in host cells that had been invaded by HCMV.

CPEB1 was also required for poly(A)-tail lengthening of viral RNAs important for productive infection. Furthermore, depletion of CPEB1 reversed infection-related cytopathology and post-transcriptional changes, and decreased productive HCMV titers.

“We found that CPEB1, one of a family of hundreds of RNA-binding proteins in the human genome, is important for establishing productive cytomegalovirus infections,” said senior author Dr. Gene Yeo, professor of cellular and molecular medicine at the University of California, San Diego. “The next steps are to determine the therapeutic value of inhibiting CPEB1 in HCMV infections and identify other RNA-binding proteins that may be important in other viral infections.”

Related Links:
University of California, San Diego


New
Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
Specimen Radiography System
TrueView 200 Pro
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The study highlights the potential of cCAFs as a biomarker for early diagnosis and prognosis (H J Woo et al., Analytical Chemistry (2025). DOI: 10.1021/acs.analchem.5c02154)

Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy

Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.